桂枝茯苓胶囊治疗慢性盆腔炎疗效分析

Curative effect analysis of Guizhi Fuling Capsule in treating chronic pelvic inflammatory disease

目的分析桂枝茯苓胶囊治疗慢性盆腔炎的临床治疗效果。方法选取2014年3月~2015年10月我院收治的慢性盆腔炎患者中选取75例进行分组治疗,将其随机分为常规组(n=36)和治疗组(n=39),常规组行常规的药物治疗,治疗组在常规治疗基础上联合桂枝茯苓胶囊治疗,观察其疗效、不良反应及症状缓解程度。结果常规组患者的总有效率结果为77.8%,治疗组患者的总有效率结果为94.9%,两组患者治疗的总有效率比较(x^2=4.734,P<0.05),常规组患者在治疗期间不良反应发生率为16.7%,治疗组患者在治疗期间不良反应发生率为2.6%,常规组患者不良反应高于治疗组患者(x^2=4.400,P<0.05)。治疗组患者治疗后盆腔积液、炎性包块存在率低于常规组患者,P<0.05,差异有统计学意义。结论桂枝茯苓胶囊治疗慢性盆腔炎,效果好,安全性高,是一种有效的治疗药物,可以广泛的应用于临床治疗中。

Objective To analyze the clinical effficacy of Guizhi Fuling capsule in the treatment of chronic pelvic inflammatory disease.Methods Seventy-five patients with chronic pelvic inflammatory disease who were admitted to our hospital from March 2014 to October 2015 were selected for group therapy.They were randomly divided into routine group （n=36） and treatment group （n=39）.The conventional group received routine drug treatment.The treatment group was treated with Guizhi Fuling Capsule on the basis of routine treatment,and its efficacy,adverse reactions and symptom relief were observed.Results The total effective rate of the conventional group was 77.8%,and the total effective rate of the treated group was 94.9%.The total effective rate of the two groups was compared （χ2=4.734,P〈0.05）.The conventional group was treated.The incidence of adverse reactions during the period was 16.7%.The incidence of adverse reactions in the treatment group was 2.6% during the treatment period.The adverse reactions in the conventional group were higher than those in the treatment group （χ2=4.400,P〈0.05）.The incidence of pelvic effusion and inflammatory mass in the treatment group was lower than that in the conventional group,p〈0.05,and the difference was statistically significant.Conclusion Guizhi Fuling Capsule is effective and safe in treating chronic pelvic inflammatory disease.It is an effective therapeutic drug and can be widely used in clinical treatment.